HPV testing for primary cervical cancer screening: a health technology assessment
Chao YS, Clark M, Carson E, Weeks L, Moulton K, McFaul S, McLauchlin CM, Tsoi B, Majid U, Kandasamy S, Arora N, Vanstone M, Reid L, Krahn T, Kaluzny K, Farrah K, Ford C
Record ID 32018002231
English
Details
Project Status:
Completed
URL for project:
https://cadth.ca/hpv-testing-primary-cervical-cancer-screening
Year Published:
2019
URL for published report:
https://cadth.ca/sites/default/files/ou-tr/op0530-hpv-testing-for-pcc-report.pdf
URL for additional information:
https://cadth.ca/hpv-testing-primary-cervical-cancer-screening
English language abstract:
An English language summary is available
Publication Type:
Full HTA
Country:
Canada
Pubmed ID:
31246380
MeSH Terms
- Uterine Cervical Neoplasms
- Mass Screening
- Cervical Intraepithelial Neoplasia
- Human papillomavirus 16
- Papillomavirus Infections
Keywords
- HPV testing
- Human papillomavirus testing
- Cervical cancer screening
Contact
Organisation Name:
Canadian Agency for Drugs and Technologies in Health
Contact Address:
600-865 Carling Avenue, Ottawa, ON K1S 5S8 Canada. Tel: +1 613 226 2553; Fax: +1 613 226 5392;
Contact Name:
requests@cadth.ca
Contact Email:
requests@cadth.ca
Copyright:
<p>Canadian Agency for Drugs and Technologies in Health (CADTH)</p>
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.